EUVIMEDEUVIMED entdecken
Crossref

Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab

William Wierda, Thomas Kipps, Jiří Mayer, Stephan Stilgenbauer, Cathy D. Williams, Andrzej Hellmann, Tadeusz Robak, Richard R. Furman, Peter Hillmen, Marek Trneny, Martin J.S. Dyer, Swami Padmanabhan und 8 weitere

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E36

DOI: 10.3816/clm.2009.n.098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von William Wierda und 19 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wierda, W., Kipps, T., Mayer, J., Stilgenbauer, S., Williams, C. D., Hellmann, A., Robak, T., Furman, R. R., Hillmen, P., Trneny, M., Dyer, M. J., Padmanabhan, S., Piotrowska, M., Kozak, T., Chan, G., Davis, R., Losic, N., Wilms, J., Russell, C., & Österborg, A. (2009). Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab. Clinical Lymphoma and Myeloma, 9(6), E36. https://doi.org/10.3816/clm.2009.n.098

Vancouver

Wierda W, Kipps T, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, et al. Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab. Clinical Lymphoma and Myeloma. 2009;9(6):E36. doi:10.3816/clm.2009.n.098

BibTeX
@article{Wierda2009,
  author = {Wierda, William and Kipps, Thomas and Mayer, Jiří and Stilgenbauer, Stephan and Williams, Cathy D. and Hellmann, Andrzej and Robak, Tadeusz and Furman, Richard R. and Hillmen, Peter and Trneny, Marek and Dyer, Martin J.S. and Padmanabhan, Swami and Piotrowska, Magdalena and Kozak, Tomas and Chan, Geoffrey and Davis, Randy and Losic, Nedjad and Wilms, Joris and Russell, Charlotte and Österborg, Anders},
  title = {Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {E36},
  doi = {10.3816/clm.2009.n.098}
}
Kostenlos starten →